Investigating the risks of Covid-19 vaccine supply chain

Jie Ma; Tommy K.H. Chan; Adrian Small

Investigating the risks of Covid-19 vaccine supply chain

Management Sciences

Research output: Chapter in Book/Conference proceeding › Conference contribution › peer-review

Abstract

The development of the Covid-19 vaccines is promising to end the pandemic. However, having a safe and efficacy vaccine is one thing, ensuring them get delivered is quite another. The ‘Great Lockdown’ has not only largely restricted the movement of people and goods, but also caused significant impacts on the delivery of PPEs and other healthcare products. This study aims to understand how supply chains can mirror the demand for Covid-19 vaccinations. It employs the Protection Motiving Theory to investigate the relationships between participants’ information on vaccine availability and their decisions on vaccine uptake.

Original language	English
Title of host publication	28th EurOMA Conference, Brighton, United Kingdom, 5/07/21
Publication status	Published - 7 Jul 2021

Cite this

@inproceedings{9db722a8ed85403dadf900d953f451d1,

title = "Investigating the risks of Covid-19 vaccine supply chain",

abstract = "The development of the Covid-19 vaccines is promising to end the pandemic. However, having a safe and efficacy vaccine is one thing, ensuring them get delivered is quite another. The {\textquoteleft}Great Lockdown{\textquoteright} has not only largely restricted the movement of people and goods, but also caused significant impacts on the delivery of PPEs and other healthcare products. This study aims to understand how supply chains can mirror the demand for Covid-19 vaccinations. It employs the Protection Motiving Theory to investigate the relationships between participants{\textquoteright} information on vaccine availability and their decisions on vaccine uptake.",

author = "Jie Ma and Chan, {Tommy K.H.} and Adrian Small",

year = "2021",

month = jul,

day = "7",

language = "English",

booktitle = "28th EurOMA Conference, Brighton, United Kingdom, 5/07/21",

}

TY - GEN

T1 - Investigating the risks of Covid-19 vaccine supply chain

AU - Ma, Jie

AU - Chan, Tommy K.H.

AU - Small, Adrian

PY - 2021/7/7

Y1 - 2021/7/7

N2 - The development of the Covid-19 vaccines is promising to end the pandemic. However, having a safe and efficacy vaccine is one thing, ensuring them get delivered is quite another. The ‘Great Lockdown’ has not only largely restricted the movement of people and goods, but also caused significant impacts on the delivery of PPEs and other healthcare products. This study aims to understand how supply chains can mirror the demand for Covid-19 vaccinations. It employs the Protection Motiving Theory to investigate the relationships between participants’ information on vaccine availability and their decisions on vaccine uptake.

AB - The development of the Covid-19 vaccines is promising to end the pandemic. However, having a safe and efficacy vaccine is one thing, ensuring them get delivered is quite another. The ‘Great Lockdown’ has not only largely restricted the movement of people and goods, but also caused significant impacts on the delivery of PPEs and other healthcare products. This study aims to understand how supply chains can mirror the demand for Covid-19 vaccinations. It employs the Protection Motiving Theory to investigate the relationships between participants’ information on vaccine availability and their decisions on vaccine uptake.

M3 - Conference contribution

BT - 28th EurOMA Conference, Brighton, United Kingdom, 5/07/21

ER -

Investigating the risks of Covid-19 vaccine supply chain

Abstract

Fingerprint

Cite this